Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 USD | +2.34% | -4.51% | -3.95% |
04-29 | Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix | CI |
03-08 | Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing | MT |
Business Summary
Number of employees: 427
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Peripheral Nerve Regeneration and Repair
100.0
%
| 139 | 100.0 % | 159 | 100.0 % | +14.74% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 139 | 100.0 % | 159 | 100.0 % | +14.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Karen Zaderej
CEO | Chief Executive Officer | 62 | 30/04/06 |
Nir Naor
DFI | Director of Finance/CFO | 50 | 12-05 |
Marc Began
CMP | Compliance Officer | 57 | 05/03/23 |
Ivica Ducic
CTO | Chief Tech/Sci/R&D Officer | - | 04/01/17 |
Gregory Freitag
BRD | Director/Board Member | 62 | 31/05/10 |
Todd Puckett
PRN | Corporate Officer/Principal | - | - |
Sales & Marketing | - | 31/12/21 | |
Jens Kemp
SAM | Sales & Marketing | - | 12/02/23 |
Erick DeVinney
PRN | Corporate Officer/Principal | 48 | 31/03/07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Thomas
BRD | Director/Board Member | 68 | 29/09/20 |
Director/Board Member | 63 | 31/08/16 | |
John Johnson
BRD | Director/Board Member | 66 | 18/07/21 |
Guido Neels
BRD | Director/Board Member | 75 | 25/08/15 |
Karen Zaderej
CEO | Chief Executive Officer | 62 | 30/04/06 |
Gregory Freitag
BRD | Director/Board Member | 62 | 31/05/10 |
Alan Levine
BRD | Director/Board Member | 63 | 14/05/19 |
William Burke
BRD | Director/Board Member | 55 | 10/07/22 |
Joseph Tyndall
BRD | Director/Board Member | 55 | 12/12/22 |
Kathy Weiler
BRD | Director/Board Member | 55 | 12-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,704,574 | 40,613,084 ( 92.93 %) | 0 | 92.93 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.95% | 287M | |
+8.33% | 219B | |
+6.72% | 183B | |
+10.18% | 132B | |
+24.91% | 106B | |
-2.21% | 62.09B | |
+10.56% | 50.8B | |
+4.81% | 50.88B | |
-0.24% | 40.64B | |
+1.22% | 35.71B |
- Stock Market
- Equities
- AXGN Stock
- Company AxoGen, Inc.